http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190037222-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a8e7ebe142a716ec8d0685edb5f205a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-302
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
filingDate 2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b7cfcab6e3ff35f27736c93666d7652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_013a71f98642283381b2138658fc429b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf55652ffe45be77d4022d0da5506617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16d1ab5b0961009cd268eddb8c117340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6978aee6eaca4e72d22ddc940ccfcfac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38fa7122f963630a297b6c01f9892314
publicationDate 2019-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20190037222-A
titleOfInvention Composition for relieving menopausal symptom comprising Tectorigenin 7-O-xylosylglucoside
abstract The present invention relates to a composition for preventing, treating or ameliorating female menopausal symptoms comprising Tectorigenin 7-O-xylosylglucoside. Since the composition according to the present invention has a rapid effect on the prevention, improvement and / or treatment of women's menopausal symptoms, especially sweating, facial flushing and / or osteoporosis, the composition according to the present invention can be used as a hormone replacement therapy (HRT).
priorityDate 2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425264416
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21881395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426131764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9543102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411830934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408652417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421183054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420230559
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21583954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449751318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154497558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7048776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21220

Total number of triples: 48.